Back
Harmony Biosciences Holdings Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
31
HRMY
Harmony Biosciences Holdings
Last Price:
$34.26
Seasonality Move:
-6.84%
Sell
33
EYPT
EyePoint Pharmaceuticals
Last Price:
$7.12
Seasonality Move:
7.64%
Sell
31
Harmony Biosciences Holdings (HRMY)
is a Sell
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
-
The current Harmony Biosciences Holdings [HRMY] share price is $34.28. The Score for HRMY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
HRMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $7.12. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $34.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRMY is experiencing slight buying pressure.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $7.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.
HRMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 53.15 | Buy |
Chaikin Money Flow: | 216449 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.69 - 34.65) | Buy |
Bollinger Bands (100): | (33.11 - 37.19) | Sell |
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 34.11 | Sell |
Chaikin Money Flow: | -639404 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.76 - 9.04) | Sell |
Bollinger Bands (100): | (7.84 - 10.36) | Sell |
HRMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.11 | Buy |
20-day SMA: | 33.85 | Buy |
50-day SMA: | 34.22 | Buy |
200-day SMA: | 33.08 | Buy |
8-day EMA: | 33.56 | Buy |
20-day EMA: | 33.65 | Buy |
50-day EMA: | 34.17 | Buy |
200-day EMA: | 33.81 | Buy |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.62 | Sell |
20-day SMA: | 8.29 | Sell |
50-day SMA: | 9.7 | Sell |
200-day SMA: | 11.63 | Sell |
8-day EMA: | 7.61 | Sell |
20-day EMA: | 8.25 | Sell |
50-day EMA: | 8.98 | Sell |
200-day EMA: | 10.9 | Sell |
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $1.11 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.
Harmony Biosciences Holdings Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
EyePoint Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |